Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial
{{output}}
Background: We compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial. Method: We conducted a multicenter, parallel-group, active-con... ...
